Position in ARDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,793,673
-$471,423 QoQ
Shares Held
3,685,034
+14.6% QoQ
Ownership
1.48%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 250 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99%
Shared 1%
None 0%
Common Shares in ARDX Over Time
Shares Held
Position Value (USD)
Derivatives in ARDX
reported options exposure · as of Mar 31, 2024CallValue
$1,095,000
CallShares
150,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. ARDX ranks #119 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in ARDX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,793,673 | 3,685,034 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $19,265,096 | 3,216,210 | Shares | Defined | 2026-05-15 | |
| 2025-09-30 | $14,242,671 | 2,584,877 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $15,693,859 | 4,003,536 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $11,679,602 | 2,378,738 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $10,937,266 | 2,157,252 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $16,328,279 | 2,369,852 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $21,649,522 | 2,921,663 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,095,000 | 150,000 | Call | Defined | 2024-05-15 | |
| 2024-03-31 | $14,537,789 | 1,991,478 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $6,845,234 | 1,104,070 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $5,177,041 | 1,268,883 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $4,755,234 | 1,402,724 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $7,946,542 | 1,658,986 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $1,117,689 | 392,172 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $19,105 | 16,055 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $197,244 | 334,313 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $291,442 | 272,376 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $667,097 | 606,452 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $699,828 | 530,173 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $3,186,798 | 420,422 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,219,206 | 486,285 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $3,387,355 | 523,548 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $5,364,879 | 1,021,882 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $4,577,413 | 661,476 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $4,148,327 | 729,697 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||